Cargando…
Asymmetric Dimethyarginine as Marker and Mediator in Ischemic Stroke
Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is known as mediator of endothelial cell dysfunction and atherosclerosis. Circulating ADMA levels are correlated with cardiovascular risk factors such as hypercholesterolemia, arterial hypertension, diabetes mel...
Autores principales: | Chen, Shufen, Li, Na, Deb-Chatterji, Milani, Dong, Qiang, Kielstein, Jan T., Weissenborn, Karin, Worthmann, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546674/ https://www.ncbi.nlm.nih.gov/pubmed/23443106 http://dx.doi.org/10.3390/ijms131215983 |
Ejemplares similares
-
Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
por: Chen, Shufen, et al.
Publicado: (2012) -
Correction: Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
por: Chen, Shufen, et al.
Publicado: (2023) -
Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke
por: Worthmann, Hans, et al.
Publicado: (2012) -
The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcome
por: Grosse, Gerrit M, et al.
Publicado: (2014) -
Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection
por: Worthmann, Hans, et al.
Publicado: (2015)